MHC-bound, SIV-derived, CTL and HTL Epitopes
MHC 结合、SIV 衍生、CTL 和 HTL 表位
基本信息
- 批准号:8133326
- 负责人:
- 金额:$ 76.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2012-03-19
- 项目状态:已结题
- 来源:
- 关键词:AIDS vaccine developmentAcquired Immunodeficiency SyndromeAllelesAmino AcidsAnimal ModelAntigensBindingBiological AssayCommon EpitopeCommunitiesCytotoxic T-LymphocytesDevelopmentEnzymesEpitopesHIVHIV vaccineHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHumanImmune responseIn SituIndividualInfectionKnowledgeLengthLettersLinkMHC Class I GenesMHC Class II GenesMacacaMacaca mulattaMeasuresMethodsModelingMonitorOpen Reading FramesPathogenesisPeptide/MHC ComplexPeptidesPlayPopulationReagentResearch PersonnelRoleSIVScanningSorting - Cell MovementSpottingsStaining methodStainsSystemT-LymphocyteT-Lymphocyte EpitopesVaccinatedVaccinesViralcohortcytokinepathogenpre-clinicalpublic health relevanceresponsesynthetic peptidetool
项目摘要
DESCRIPTION (provided by applicant): With more than 30 million HIV-infected individuals, there can be few other more pressing biomedical priorities than to produce an effective vaccine for HIV. Given the important role that cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) play in controlling viral replication, it is critical that this vaccine stimulates these cellular responses. Current methods of detecting vaccine-induced immune responses include Intra-Cellular Cytokine Staining (ICS), Enzyme-Linked Spot-Forming Assays (ELISPOT), and tetramer staining. ICS and ELISPOT can be carried out using peptides of 10-15 amino acids in length. However, depending on where the true epitope lies in the synthetic peptide, these peptide sets may not accurately detect the magnitude of the immune response. The identification of minimal optimal epitopes is the best method to accurately assess cellular immune responses. Furthermore, the synthesis of tetramers is absolutely dependent on knowledge of the minimal optimal epitope. Finally, we recently discovered that there are several MHC class l-restricted epitopes in SIV cryptic Open Reading Frames (cORFs). We, therefore, propose to continue our definition of minimal optimal epitopes for common Indian rhesus macaque class I and II molecules in both classical and cryptic ORFs in SIV.
PUBLIC HEALTH RELEVANCE (provided by applicant): SIV infection in Indian rhesus macaques is the best animal model for studying HIV-infected humans. SIV challenge of vaccinated Indian rhesus macaques is one of the best defined models available for pre-clinical development of HIV vaccines. Identification of MHC alleles and definition of SIV-specific epitopes is critical in the definition of the immune response in this biomedically important system.
描述(由申请人提供):有3000多万艾滋病毒感染者,没有什么比生产有效的艾滋病毒疫苗更紧迫的生物医学优先事项了。鉴于细胞毒性T淋巴细胞(ctl)和辅助性T淋巴细胞(HTLs)在控制病毒复制中发挥的重要作用,这种疫苗刺激这些细胞反应是至关重要的。目前检测疫苗诱导的免疫反应的方法包括细胞内细胞因子染色(ICS)、酶联斑点形成试验(ELISPOT)和四聚体染色。ICS和ELISPOT可以使用长度为10-15个氨基酸的肽进行检测。然而,取决于真正的表位在合成肽中的位置,这些肽集可能不能准确地检测免疫反应的大小。最小最优表位的鉴定是准确评估细胞免疫应答的最佳方法。此外,四聚体的合成完全依赖于最小最佳表位的知识。最后,我们最近发现在SIV隐式开放阅读框(corf)中存在几个MHC l类限制性表位。因此,我们建议在SIV的经典orf和隐orf中继续我们对印度恒河猴常见的I类和II类分子的最小最佳表位的定义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David I Watkins其他文献
HIV pathogenesis: the first cut is the deepest
艾滋病病毒发病机制:初次感染影响最为深远
- DOI:
10.1038/ni0505-430 - 发表时间:
2005-05-01 - 期刊:
- 影响因子:27.600
- 作者:
Louis J Picker;David I Watkins - 通讯作者:
David I Watkins
David I Watkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David I Watkins', 18)}}的其他基金
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10422995 - 财政年份:2021
- 资助金额:
$ 76.39万 - 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10669613 - 财政年份:2021
- 资助金额:
$ 76.39万 - 项目类别:
Learning from the Ebola success: Can a mAb also save lives after yellow fever infection?
借鉴埃博拉病毒的成功经验:单克隆抗体也能拯救黄热病感染后的生命吗?
- 批准号:
10463875 - 财政年份:2021
- 资助金额:
$ 76.39万 - 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8787712 - 财政年份:2014
- 资助金额:
$ 76.39万 - 项目类别:
Can vaccine-induced CD8 T cells prevent chronic phase AIDS virus replication?
疫苗诱导的 CD8 T 细胞能否阻止慢性期艾滋病病毒复制?
- 批准号:
8976140 - 财政年份:2014
- 资助金额:
$ 76.39万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8497605 - 财政年份:2012
- 资助金额:
$ 76.39万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8688135 - 财政年份:2012
- 资助金额:
$ 76.39万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8301117 - 财政年份:2012
- 资助金额:
$ 76.39万 - 项目类别:
Yellow Fever, rDNA (EP+IL-12) and rAd35 as Vectors for AIDS Vaccine Development
黄热病、rDNA (EP IL-12) 和 rAd35 作为艾滋病疫苗开发的载体
- 批准号:
8874851 - 财政年份:2012
- 资助金额:
$ 76.39万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 76.39万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 76.39万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 76.39万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 76.39万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 76.39万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 76.39万 - 项目类别:
Studies on cofactors for development of acquired immunodeficiency syndrome in feline immunodeficiency virus infection.
猫免疫缺陷病毒感染后获得性免疫缺陷综合征发生的辅助因子研究。
- 批准号:
03660315 - 财政年份:1991
- 资助金额:
$ 76.39万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 76.39万 - 项目类别: